These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26762168)

  • 21. High frequency stimulation of subthalamic nucleus results in behavioral recovery by increasing striatal dopamine release in 6-hydroxydopamine lesioned rat.
    He Z; Jiang Y; Xu H; Jiang H; Jia W; Sun P; Xie J
    Behav Brain Res; 2014 Apr; 263():108-14. PubMed ID: 24462728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sonic hedgehog delivered by an adeno-associated virus protects dopaminergic neurones against 6-OHDA toxicity in the rat.
    Dass B; Iravani MM; Huang C; Barsoum J; Engber TM; Galdes A; Jenner P
    J Neural Transm (Vienna); 2005 Jun; 112(6):763-78. PubMed ID: 15586304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activin A protects midbrain neurons in the 6-hydroxydopamine mouse model of Parkinson's disease.
    Stayte S; Rentsch P; Li KM; Vissel B
    PLoS One; 2015; 10(4):e0124325. PubMed ID: 25902062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unilateral Intrastriatal 6-Hydroxydopamine Lesion in Mice: A Closer Look into Non-Motor Phenotype and Glial Response.
    Mendes-Pinheiro B; Soares-Cunha C; Marote A; Loureiro-Campos E; Campos J; Barata-Antunes S; Monteiro-Fernandes D; Santos D; Duarte-Silva S; Pinto L; José Salgado A
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat.
    Kirik D; Rosenblad C; Björklund A
    Exp Neurol; 1998 Aug; 152(2):259-77. PubMed ID: 9710526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Respiratory deficits in a rat model of Parkinson's disease.
    Tuppy M; Barna BF; Alves-Dos-Santos L; Britto LR; Chiavegatto S; Moreira TS; Takakura AC
    Neuroscience; 2015 Jun; 297():194-204. PubMed ID: 25838118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acetyl-l-carnitine protects dopaminergic nigrostriatal pathway in 6-hydroxydopamine-induced model of Parkinson's disease in the rat.
    Afshin-Majd S; Bashiri K; Kiasalari Z; Baluchnejadmojarad T; Sedaghat R; Roghani M
    Biomed Pharmacother; 2017 May; 89():1-9. PubMed ID: 28199883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior.
    Carman LS; Gage FH; Shults CW
    Brain Res; 1991 Jul; 553(2):275-83. PubMed ID: 1681983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methodology and effects of repeated intranasal delivery of DNSP-11 in a rat model of Parkinson's disease.
    Stenslik MJ; Potts LF; Sonne JW; Cass WA; Turchan-Cholewo J; Pomerleau F; Huettl P; Ai Y; Gash DM; Gerhardt GA; Bradley LH
    J Neurosci Methods; 2015 Aug; 251():120-9. PubMed ID: 25999268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of unilateral and bilateral intrastriatal 6-hydroxydopamine-induced axon terminal lesions: evidence for interhemispheric functional coupling of the two nigrostriatal pathways.
    Roedter A; Winkler C; Samii M; Walter GF; Brandis A; Nikkhah G
    J Comp Neurol; 2001 Apr; 432(2):217-29. PubMed ID: 11241387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nigrostriatal damage with 6-OHDA: validation of routinely applied procedures.
    Fulceri F; Biagioni F; Lenzi P; Falleni A; Gesi M; Ruggieri S; Fornai F
    Ann N Y Acad Sci; 2006 Aug; 1074():344-8. PubMed ID: 17105931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of unilateral 6-OHDA lesion in medial forebrain bundle on the motor, cognitive dysfunctions and vulnerability of different striatal interneuron types in rats.
    Ma Y; Zhan M; OuYang L; Li Y; Chen S; Wu J; Chen J; Luo C; Lei W
    Behav Brain Res; 2014 Jun; 266():37-45. PubMed ID: 24613235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic infusion of CDNF prevents 6-OHDA-induced deficits in a rat model of Parkinson's disease.
    Voutilainen MH; Bäck S; Peränen J; Lindholm P; Raasmaja A; Männistö PT; Saarma M; Tuominen RK
    Exp Neurol; 2011 Mar; 228(1):99-108. PubMed ID: 21185834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of depressive-like behavior by intranigral 6-OHDA is directly correlated with deficits in striatal dopamine and hippocampal serotonin.
    Santiago RM; Barbiero J; Gradowski RW; Bochen S; Lima MM; Da Cunha C; Andreatini R; Vital MA
    Behav Brain Res; 2014 Feb; 259():70-7. PubMed ID: 24183944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reactive oxidative and nitrogen species in the nigrostriatal system following striatal 6-hydroxydopamine lesion in rats.
    Henze C; Earl C; Sautter J; Schmidt N; Themann C; Hartmann A; Oertel WH
    Brain Res; 2005 Aug; 1052(1):97-104. PubMed ID: 16005444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
    Lee EY; Lee JE; Park JH; Shin IC; Koh HC
    Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of magnesium transporter SLC41A1 in the striatum of 6-hydroxydopamine-induced parkinsonian rats.
    Lin L; Yan M; Wu B; Lin R; Zheng Z
    Brain Res Bull; 2018 Sep; 142():338-343. PubMed ID: 30172737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
    Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
    J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serofendic acid prevents 6-hydroxydopamine-induced nigral neurodegeneration and drug-induced rotational asymmetry in hemi-parkinsonian rats.
    Inden M; Kitamura Y; Kondo J; Hayashi K; Yanagida T; Takata K; Tsuchiya D; Yanagisawa D; Nishimura K; Taniguchi T; Shimohama S; Sugimoto H; Akaike A
    J Neurochem; 2005 Nov; 95(4):950-61. PubMed ID: 16135081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of AdGDNF on dopaminergic neurotransmission in the striatum of 6-OHDA-treated rats.
    Smith AD; Kozlowski DA; Bohn MC; Zigmond MJ
    Exp Neurol; 2005 Jun; 193(2):420-6. PubMed ID: 15869944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.